|
|
|
| home > white papers > Pandemic respiratory vaccine clinical trials: a departure from business as usual - ICON plc |
|
|
 WHITE PAPERS |
|
ICON plc
|
|
Pandemic respiratory vaccine clinical trials: a departure from business as usual
|
|
Around the world, the “V” words are on everyone’s lips: Virus and Vaccines. In response to the urgent need for a vaccine for COVID-19, researchers are, at time of publication, running 500+ clinical trials (and counting) on a number of antivirals, antibodies and vaccines. Promising possibilities range from novel new drugs/vaccines, repurposing treatments currently indicated for HIV, Ebola and malaria, to monoclonal antibodies and immune serum.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Avantor® Opens Single-Use Logistics Hub to Strengthen Global Biopharma Supply Chain
New facility in Westminster, Mass., provides reliable and comprehensive support for single-use business.
More info >> |
|
 |
White Papers |
 |
|
|
|
